Aptevo Therapeutics Inc
NASDAQ:APVO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
US |
|
C
|
Capita PLC
OTC:CTAGF
|
UK |
|
Bufab AB (publ)
STO:BUFAB
|
SE |
|
P
|
Power and Water Utility Company for Jubail and Yanbu SJSC
SAU:2083
|
SA |
|
Teleperformance SE
F:RCF0
|
FR |
|
T
|
Thales SA
SWB:CSF
|
FR |
|
L
|
Lucara Diamond Corp
OTC:LUCRF
|
CA |
|
Lincoln Electric Holdings Inc
NASDAQ:LECO
|
US |
|
U
|
UBA Investments Ltd
HKEX:768
|
HK |
|
V
|
Vale SA
SWB:CVLC
|
BR |
|
Orient Overseas (International) Ltd
F:ORI
|
HK |
|
Barry Callebaut AG
SIX:BARN
|
CH |
|
Entreparticuliers.com SA
PAR:ALENT
|
FR |
|
Murchison Minerals Ltd
XTSX:MUR
|
CA |
|
B
|
BP PLC
F:BPE5
|
UK |
|
Asics Corp
F:ASI1
|
JP |
|
Y
|
Yangzijiang Maritime Development Pte Ltd
SGX:8YZ
|
SG |
|
Illumina Inc
NASDAQ:ILMN
|
US |
|
E
|
Emerson Electric Co
XMUN:EMR
|
US |
|
W
|
Wolford AG
VSE:WOL
|
AT |
|
PG&E Corp
NYSE:PCG
|
US |
|
I
|
Ingredion Inc
SWB:CNP
|
US |
|
A
|
Arbor Realty Trust Inc
F:OWQ
|
US |
|
B
|
Banco Santander Brasil SA
SWB:DBSA
|
BR |
Bankruptcy Probability
Aptevo Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptevo Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
2.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptevo Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptevo Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.